LTBK-01: PROSPECTIVE, MULTI-CENTER PHASE III TRIAL OF TUMOR TREATING FIELDS TOGETHER WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

BACKGROUND: Tumor Treating Fields (TTFields) is an established, frequency-tuned, anti-mitotic, physical treatment modality that acts in metaphase, anaphase and telophase. TTFields are delivered to the brain by a patient operated, portable medical device (Optune™, Novocure Ltd.). An international, mu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro Oncol
Hauptverfasser: Stupp, Roger, Idbaih, Ahmed, Steinberg, David M., Read, William, Toms, Steven, Barnett, Gene, Nicholas, Garth, Kim, Chae-Yong, Fink, Karen, Salmaggi, Andrea, Lieberman, Frank, Zhu, Jay, Taylor, Lynne, Stragliotto, Giuseppe, Hottinger, Andreas, Kirson, Eilon D., Weinberg, Uri, Palti, Yoram, Hegi, Monika E., Ram, Zvi
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2016
Schlagworte:
Late Breaking Abstract
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5772218/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now260
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge